Long-term treatment with ximelagatran, an oral direct thrombin inhibitor, persistently reduces the coagulation activity after a myocardial infarction

✍ Scribed by C. CHRISTERSSON; J. OLDGREN; A. BYLOCK; L. WALLENTIN; A. SIEGBAHN

• Book ID: 109149178
• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 347 KB
• Volume: 3
• Category: Article
• ISSN: 1538-7933
• DOI: 10.1111/j.1538-7836.2005.01557.x